Forlong Biotechnology
Latest round
- Series A
Last raised
- Feb 2023
Total raised
- $15M
Investors
- 6
About Forlong Biotechnology
, trading as Forlong Biotechnology, is a clinical-stage biotechnology company focusing on the development of next-generation cytokine drugs. The company has established a clinical department and a R&D Department in Shanghai, China. Its founder and CEO, Dr. Tianlei Ying, previously served as an investigator at the National Cancer Institute (NCI), USA. Forlong Biotechnology has developed multiple drug pipelines for the treatment of cancer. The company's core pipeline FL115 is an engineered IL-15/IL15Ra-Fbody fusion protein that exerts anti-tumor effects by activating NK cells and memory T cells for treating non-muscle-invasive bladder cancer (NMIBC). Forlong Biotechnology also offers other pipelines such as FL117, FL118 and FL301 for the treatment of solid tumors. The company's revenue is generated by developing engineered therapeutic cytokine combinations that target different stages of the cancer-immune cycle to treat cancer.
Who invested in Forlong Biotechnology
6 investors across 1 round
See all investors in Forlong Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 6, 2023
Amount
$15M
Investors
Questions about Forlong Biotechnology
Who invested in Forlong Biotechnology?
Forlong Biotechnology has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Forlong Biotechnology raised?
Forlong Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Forlong Biotechnology last raise money?
Forlong Biotechnology's most recent round on record is a Series A, in Feb 2023.
What does Forlong Biotechnology do?
, trading as Forlong Biotechnology, is a clinical-stage biotechnology company focusing on the development of next-generation cytokine drugs.
Where is Forlong Biotechnology headquartered?
Forlong Biotechnology is headquartered in Suzhou, China.
Which VCs invest in companies like Forlong Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Forlong Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Forlong Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.